SECOND REGULAR SESSION
HOUSE BILL NO. 2295
102ND GENERAL ASSEMBLY
INTRODUCED BY REPRESENTATIVE INGLE.
4614H.02I DANARADEMANMILLER,ChiefClerk
AN ACT
To repeal section 338.010, RSMo, and to enact in lieu thereof two new sections relating to
contraceptives.
Be it enacted by the General Assembly of the state of Missouri, as follows:
Section A. Section 338.010, RSMo, is repealed and two new sections enacted in lieu
2 thereof, to be known as sections 338.010 and 338.720, to read as follows:
338.010. 1. The "practice of pharmacy" includes:
2 (1) Theinterpretation,implementation,andevaluationofmedicalprescriptionorders,
3 including any legend drugs under 21 U.S.C. Section 353, and the receipt, transmission, or
4 handling of such orders or facilitating the dispensing of such orders;
5 (2) The designing, initiating, implementing, and monitoring of a medication
6 therapeutic plan in accordance with the provisions of this section;
7 (3) The compounding, dispensing, labeling, and administration of drugs and devices
8 pursuant to medical prescription orders;
9 (4) The ordering and administration of vaccines approved or authorized by the U.S.
10 Food and Drug Administration, excluding vaccines for cholera, monkeypox, Japanese
11 encephalitis, typhoid, rabies, yellow fever, tick-borne encephalitis, anthrax, tuberculosis,
12 dengue, Hib, polio, rotavirus, smallpox, and any vaccine approved after January 1, 2023, to
13 persons at least seven years of age or the age recommended by the Centers for Disease
14 Control and Prevention, whichever is older, pursuant to joint promulgation of rules
15 established by the board of pharmacy and the state board of registration for the healing arts
16 unless rules are established under a state of emergency as described in section 44.100;
EXPLANATION â€” Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is
intended to be omitted from the law. Matter in bold-face type in the above bill is proposed language.
HB 2295 2
17 (5) Theparticipationindrugselectionaccordingtostatelawandparticipationindrug
18 utilization reviews;
19 (6) The proper and safe storage of drugs and devices and the maintenance of proper
20 records thereof;
21 (7) Consultation with patients and other health care practitioners, and veterinarians
22 and their clients about legend drugs, about the safe and effective use of drugs and devices;
23 (8) Theprescribinganddispensingofanynicotinereplacementtherapyproductunder
24 section 338.665;
25 (9) The dispensing of HIV postexposure prophylaxis pursuant to section 338.730;
26 [and]
27 (10) The dispensing of self-administered hormonal contraceptives under section
28 338.720; and
29 (11) The offering or performing of those acts, services, operations, or transactions
30 necessary in the conduct, operation, management and control of a pharmacy.
31 2. No person shall engage in the practice of pharmacy unless he or she is licensed
32 under the provisions of this chapter.
33 3. This chapter shall not be construed to prohibit the use of auxiliary personnel under
34 thedirectsupervisionofapharmacistfromassistingthepharmacistinanyofhisorherduties.
35 Thisassistance in no way is intended to relieve the pharmacist fromhis or herresponsibilities
36 for compliance with this chapter and he or she will be responsible for the actions of the
37 auxiliary personnel acting in his or her assistance.
38 4. This chapter shall not be construed to prohibit or interfere with any legally
39 registered practitioner of medicine, dentistry, or podiatry, or veterinary medicine only for use
40 in animals, or the practice of optometry in accordance with and as provided in sections
41 195.070 and 336.220 in the compounding, administering, prescribing, or dispensing of his or
42 her own prescriptions.
43 5. A pharmacist with a certificate of medication therapeutic plan authority may
44 provide medication therapy services pursuant to a written protocol from a physician licensed
45 under chapter 334 to patients who have established a physician-patient relationship, as
46 described in subdivision (1) of subsection 1 of section 191.1146, with the protocol physician.
47 The written protocol authorized by this section shall come only from the physician and shall
48 not come from a nurse engaged in a collaborative practice arrangement under section
49 334.104, or from a physician assistant engaged in a collaborative practice arrangement under
50 section 334.735.
51 6. Nothing in this section shall be construed as to prevent any person, firm or
52 corporation from owning a pharmacy regulated by sections 338.210 to 338.315, provided that
53 a licensed pharmacist is in charge of such pharmacy.
HB 2295 3
54 7. Nothing in this section shall be construed to apply to or interfere with the sale of
55 nonprescription drugs and the ordinary household remedies and such drugs or medicines as
56 are normally sold by those engaged in the sale of general merchandise.
57 8. No health carrier as defined in chapter 376 shall require any physician with which
58 they contract to enter into a written protocol with a pharmacist for medication therapeutic
59 services.
60 9. This section shall not be construed to allow a pharmacist to diagnose or
61 independently prescribe pharmaceuticals.
62 10. The state board of registration for the healing arts, under section 334.125, and the
63 state board of pharmacy, under section 338.140, shall jointly promulgate rules regulating the
64 useofprotocolsformedicationtherapyservices. Suchrulesshallrequireprotocolstoinclude
65 provisions allowing for timely communication between the pharmacist and the protocol
66 physician or similar body authorized by this section, and any other patient protection
67 provisions deemed appropriate by both boards. In order to take effect, such rules shall be
68 approved by a majority vote of a quorum of each board. Neither board shall separately
69 promulgate rules regulating the use of protocols for medication therapy services. Any rule or
70 portion of a rule, as that term is defined in section 536.010, that is created under the authority
71 delegatedin thissection shallbecomeeffective onlyifit complieswithandissubject toall of
72 the provisions of chapter 536 and, if applicable, section 536.028. This section and chapter
73 536 are nonseverable and if any of the powers vested with the general assembly pursuant to
74 chapter 536 to review, to delay the effective date, or to disapprove and annul a rule are
75 subsequently held unconstitutional, then the grant of rulemaking authority and any rule
76 proposed or adopted after August 28, 2007, shall be invalid and void.
77 11. The state board of pharmacy may grant a certificate of medication therapeutic
78 plan authority to a licensed pharmacist who submits proof of successful completion of a
79 board-approved course of academic clinical study beyond a bachelor of science in pharmacy,
80 including but not limited to clinical assessment skills, from a nationally accredited college or
81 university, or a certification of equivalence issued by a nationally recognized professional
82 organization and approved by the board of pharmacy.
83 12. Any pharmacist who has received a certificate of medication therapeutic plan
84 authority may engage in the designing, initiating, implementing, and monitoring of a
85 medication therapeutic plan as defined by a written protocol from a physician that may be
86 specific to each patient for care by a pharmacist.
87 13. Nothing in this section shall be construed to allow a pharmacist to make a
88 therapeutic substitution of a pharmaceutical prescribed by a physician unless authorized by
89 the written protocol or the physician's prescription order.
HB 2295 4
90 14. "Veterinarian", "doctor of veterinary medicine", "practitioner of veterinary
91 medicine","DVM","VMD","BVSe","BVMS","BSe(VetScience)","VMB","MRCVS",or
92 an equivalent title means a person who has received a doctor's degree in veterinary medicine
93 from an accredited school of veterinary medicine or holds an Educational Commission for
94 Foreign Veterinary Graduates (EDFVG) certificate issued by the American Veterinary
95 Medical Association (AVMA).
96 15. Inadditiontootherrequirementsestablishedbythejointpromulgationofrulesby
97 the board of pharmacy and the state board of registration for the healing arts:
98 (1) A pharmacist shall administer vaccines by protocol in accordance with treatment
99 guidelines established by the Centers for Disease Control and Prevention (CDC);
100 (2) A pharmacist who is administering a vaccine shall request a patient to remain in
101 the pharmacy a safe amount of time after administering the vaccine to observe any adverse
102 reactions. Such pharmacist shall have adopted emergency treatment protocols.
103 16. In addition to other requirements by the board, a pharmacist shall receive
104 additional training as required by the board and evidenced by receiving a certificate from the
105 board upon completion, and shall display the certification in his or her pharmacy where
106 vaccines are delivered.
107 17. A pharmacist shall inform the patient that the administration of a vaccine will be
108 entered into the ShowMeVax system, as administered by the department of health and senior
109 services. Thepatientshallattestto theinclusionofsuchinformationin thesystemby signing
110 a form provided by the pharmacist. If the patient indicates that he or she does not want such
111 information entered into the ShowMeVax system, the pharmacist shall provide a written
112 reportwithinfourteendays ofadministrationofavaccinetothepatient'shealthcareprovider,
113 if provided by the patient, containing:
114 (1) The identity of the patient;
115 (2) The identity of the vaccine or vaccines administered;
116 (3) The route of administration;
117 (4) The anatomic site of the administration;
118 (5) The dose administered; and
119 (6) The date of administration.
120 18. A pharmacist licensed under this chapter may order and administer vaccines
121 approved or authorized by the U.S. Food and Drug Administration to address a public health
122 need, as lawfully authorized by the state or federal government, or a department or agency
123 thereof, during a state or federally declared public health emergency.
338.720. 1. For purposes of this section, the term "self-administered hormonal
2 contraceptive" shall mean a drug composed of one or more hormones that is approved
3 by the United States Food and Drug Administration to prevent pregnancy.
HB 2295 5
4 2. A pharmacist may dispense self-administered hormonal contraceptives to a
5 person under a prescription order for medication therapy services as described in
6 section 338.010. A prescription order for a self-administered hormonal contraceptive
7 shall have no expiration date.
8 3. The board of pharmacy, under section 338.140, and the board of registration
9 for the healing arts, under section 334.125, shall jointly promulgate rules regulating the
10 use of protocols for prescription orders for self-administered hormonal contraceptives.
11 Any rule or portion of a rule, as that term is defined in section 536.010, that is created
12 under the authority delegated in this section shall become effective only if it complies
13 with and is subject to all of the provisions of chapter 536 and, if applicable, section
14 536.028. This section and chapter 536 are nonseverable, and if any of the powers vested
15 with the general assembly pursuant to chapter 536 to review, to delay the effective date,
16 ortodisapproveandannul arulearesubsequentlyheldunconstitutional,thenthegrant
17 of rulemaking authority and any rule proposed or adopted after August 28, 2024, shall
18 be invalid and void.
19 4. The rules adopted under this section shall require a pharmacist to:
20 (1) Complete a training program approved by the board of pharmacy that is
21 related to dispensing self-administered hormonal contraceptives under this section;
22 (2) Provide a self-screening risk assessment tool that the patient shall use prior
23 to the pharmacist's dispensing the self-administered hormonal contraceptive under this
24 section;
25 (3) At least once every twelve months, verbally refer the patient to the health
26 care provider with whom the pharmacist has a prescription order before dispensing the
27 self-administered hormonal contraceptive to the patient;
28 (4) Provide the patient with a written record of the self-administered hormonal
29 contraceptive dispensed and advise the patient to consult with a health care provider;
30 and
31 (5) Dispense the self-administered hormonal contraceptive to the patient as soon
32 as practicable.
33 5. All state and federal laws governing insurance coverage of contraceptive
34 drugs, devices, products, and services shall apply to self-administered hormonal
35 contraceptives dispensed by a pharmacist under this section.
36 6. Nothing in this section shall be construed to allow a pharmacist to make a
37 therapeutic substitution of a pharmaceutical prescribed by a physician unless
38 authorized by the written protocol or the physician's written prescription order.
âœ”